{"entity":{"type":"insider","cik":"0001691090","url":"/insider/0001691090","json_url":"/insider/0001691090.json","name":"Feener Edward P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":24,"first":"2019-01-18","last":"2024-05-21","span_basis":"filed_date"},"name_variants":[{"name":"Feener Edward P.","source":"filing","n_filings":24,"first_seen":"2019-01-18","last_seen":"2024-05-21"}],"transactions":[{"id":2602635,"accession":"0001415889-24-014007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-014007","line_url":"/filing/0001415889-24-014007#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8088.0,"shares_display":"8,088","price_per_share":11.7645,"price_display":"11.76","price_state":"stated","total_value":95151.276,"total_display":"95,151.28","total_whole":"95,151","shares_owned_after":72858.0,"shares_owned_after_display":"72,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-21","scope":"insider"},{"id":3052741,"accession":"0001415889-24-004718","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-004718","line_url":"/filing/0001415889-24-004718","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28288.0,"shares_display":"28,288","price_per_share":14.067060456730768,"price_display":"14.07","price_state":"stated","total_value":397929.0062,"total_display":"397,929.01","total_whole":"397,929","shares_owned_after":62457.0,"shares_owned_after_display":"62,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider","n_lines":3},{"id":2521880,"accession":"0001415889-24-004118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-004118","line_url":"/filing/0001415889-24-004118#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28171.0,"shares_display":"28,171","price_per_share":15.0093,"price_display":"15.01","price_state":"stated","total_value":422826.9903,"total_display":"422,826.99","total_whole":"422,827","shares_owned_after":71657.0,"shares_owned_after_display":"71,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-16","scope":"insider"},{"id":2506141,"accession":"0001209191-24-001515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001515","line_url":"/filing/0001209191-24-001515#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22679.0,"shares_display":"22,679","price_per_share":13.0303,"price_display":"13.03","price_state":"stated","total_value":295514.1737,"total_display":"295,514.17","total_whole":"295,514","shares_owned_after":39828.0,"shares_owned_after_display":"39,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider"},{"id":2382274,"accession":"0001209191-24-001391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001391","line_url":"/filing/0001209191-24-001391#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":1300.0,"total_display":"1,300.00","total_whole":"1,300","shares_owned_after":62507.0,"shares_owned_after_display":"62,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider"},{"id":2382270,"accession":"0001209191-24-001391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001391","line_url":"/filing/0001209191-24-001391#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17221.0,"shares_display":"17,221","price_per_share":13.0074,"price_display":"13.01","price_state":"stated","total_value":224000.4354,"total_display":"224,000.44","total_whole":"224,000","shares_owned_after":62607.0,"shares_owned_after_display":"62,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-10","scope":"insider"},{"id":8023781,"accession":"0001209191-23-056276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-056276","line_url":"/filing/0001209191-23-056276#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4958.0,"shares_display":"4,958","price_per_share":8.2293,"price_display":"8.23","price_state":"stated","total_value":40800.8694,"total_display":"40,800.87","total_whole":"40,801","shares_owned_after":79828.0,"shares_owned_after_display":"79,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":7816293,"accession":"0001209191-23-046823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-046823","line_url":"/filing/0001209191-23-046823#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4976.0,"shares_display":"4,976","price_per_share":10.7287,"price_display":"10.73","price_state":"stated","total_value":53386.0112,"total_display":"53,386.01","total_whole":"53,386","shares_owned_after":73289.0,"shares_owned_after_display":"73,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-21","scope":"insider"},{"id":8112324,"accession":"0001209191-23-031293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-031293","line_url":"/filing/0001209191-23-031293#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1786.0,"shares_display":"1,786","price_per_share":10.1444,"price_display":"10.14","price_state":"stated","total_value":18117.8984,"total_display":"18,117.90","total_whole":"18,118","shares_owned_after":66771.0,"shares_owned_after_display":"66,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":7949469,"accession":"0001209191-23-012318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-012318","line_url":"/filing/0001209191-23-012318#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2228.0,"shares_display":"2,228","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":17066.48,"total_display":"17,066.48","total_whole":"17,066","shares_owned_after":64352.0,"shares_owned_after_display":"64,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-23","scope":"insider"},{"id":6278866,"accession":"0001209191-22-058128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058128","line_url":"/filing/0001209191-22-058128#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":2883.2,"total_display":"2,883.20","total_whole":"2,883","shares_owned_after":62376.0,"shares_owned_after_display":"62,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":6149465,"accession":"0001209191-22-046882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046882","line_url":"/filing/0001209191-22-046882#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":532.0,"shares_display":"532","price_per_share":14.9619,"price_display":"14.96","price_state":"stated","total_value":7959.7308,"total_display":"7,959.73","total_whole":"7,960","shares_owned_after":61132.0,"shares_owned_after_display":"61,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":4957175,"accession":"0001209191-21-062736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-062736","line_url":"/filing/0001209191-21-062736#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":18.0706,"price_display":"18.07","price_state":"stated","total_value":108423.6,"total_display":"108,423.60","total_whole":"108,424","shares_owned_after":2234.0,"shares_owned_after_display":"2,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4669975,"accession":"0001209191-21-049799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-049799","line_url":"/filing/0001209191-21-049799#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":20.5223,"price_display":"20.52","price_state":"stated","total_value":123133.8,"total_display":"123,133.80","total_whole":"123,134","shares_owned_after":8234.0,"shares_owned_after_display":"8,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":4274157,"accession":"0001209191-21-037887","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-037887","line_url":"/filing/0001209191-21-037887","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8200.0,"shares_display":"8,200","price_per_share":26.42631268292683,"price_display":"26.43","price_state":"stated","total_value":216695.764,"total_display":"216,695.76","total_whole":"216,696","shares_owned_after":15296.0,"shares_owned_after_display":"15,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":4274147,"accession":"0001209191-21-037887","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-037887","line_url":"/filing/0001209191-21-037887","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25800.0,"shares_display":"25,800","price_per_share":26.80871846511628,"price_display":"26.81","price_state":"stated","total_value":691664.9364,"total_display":"691,664.94","total_whole":"691,665","shares_owned_after":22448.0,"shares_owned_after_display":"22,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":9271510,"accession":"0001209191-21-031013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-031013","line_url":"/filing/0001209191-21-031013#line-1","is_derivative":false,"issuer_cik":"0001691090","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001691090","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":24.8418,"price_display":"24.84","price_state":"stated","total_value":149050.8,"total_display":"149,050.80","total_whole":"149,051","shares_owned_after":48234.0,"shares_owned_after_display":"48,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-07","scope":"insider"},{"id":4936671,"accession":"0001209191-21-030753","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-030753","line_url":"/filing/0001209191-21-030753#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":24.8418,"price_display":"24.84","price_state":"stated","total_value":149050.8,"total_display":"149,050.80","total_whole":"149,051","shares_owned_after":54234.0,"shares_owned_after_display":"54,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-06","scope":"insider"},{"id":4138248,"accession":"0001209191-21-014516","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-014516","line_url":"/filing/0001209191-21-014516","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31000.0,"shares_display":"31,000","price_per_share":33.601368032258065,"price_display":"33.60","price_state":"stated","total_value":1041642.409,"total_display":"1,041,642.41","total_whole":"1,041,642","shares_owned_after":60505.0,"shares_owned_after_display":"60,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-25","scope":"insider","n_lines":4},{"id":2559158,"accession":"0001209191-20-056919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-056919","line_url":"/filing/0001209191-20-056919#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":17.1353,"price_display":"17.14","price_state":"stated","total_value":102811.8,"total_display":"102,811.80","total_whole":"102,812","shares_owned_after":72734.0,"shares_owned_after_display":"72,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":2344882,"accession":"0001209191-20-055589","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-055589","line_url":"/filing/0001209191-20-055589","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9007.0,"shares_display":"9,007","price_per_share":18.311120339735762,"price_display":"18.31","price_state":"stated","total_value":164928.2609,"total_display":"164,928.26","total_whole":"164,928","shares_owned_after":78734.0,"shares_owned_after_display":"78,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-21","filed_date":"2020-10-22","scope":"insider","n_lines":2},{"id":2344871,"accession":"0001209191-20-055589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055589","line_url":"/filing/0001209191-20-055589","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7900.0,"shares_display":"7,900","price_per_share":17.479789873417722,"price_display":"17.48","price_state":"stated","total_value":138090.34,"total_display":"138,090.34","total_whole":"138,090","shares_owned_after":90041.0,"shares_owned_after_display":"90,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-20","filed_date":"2020-10-22","scope":"insider","n_lines":2},{"id":2738515,"accession":"0001209191-20-055363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055363","line_url":"/filing/0001209191-20-055363#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":993.0,"shares_display":"993","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":16881.0,"total_display":"16,881.00","total_whole":"16,881","shares_owned_after":95641.0,"shares_owned_after_display":"95,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-16","filed_date":"2020-10-20","scope":"insider"},{"id":2849830,"accession":"0001567619-20-002453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-002453","line_url":"/filing/0001567619-20-002453#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.11,"price_display":"17.11","price_state":"stated","total_value":1711.0,"total_display":"1,711.00","total_whole":"1,711","shares_owned_after":96634.0,"shares_owned_after_display":"96,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider"},{"id":8487080,"accession":"0001567619-19-015141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-015141","line_url":"/filing/0001567619-19-015141#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":18.6521,"price_display":"18.65","price_state":"stated","total_value":35438.99,"total_display":"35,438.99","total_whole":"35,439","shares_owned_after":96734.0,"shares_owned_after_display":"96,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-23","filed_date":"2019-07-24","scope":"insider"},{"id":8487074,"accession":"0001567619-19-015141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-015141","line_url":"/filing/0001567619-19-015141#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":18.5743,"price_display":"18.57","price_state":"stated","total_value":26004.02,"total_display":"26,004.02","total_whole":"26,004","shares_owned_after":98634.0,"shares_owned_after_display":"98,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-24","scope":"insider"},{"id":8631046,"accession":"0001567619-19-008965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-008965","line_url":"/filing/0001567619-19-008965","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":24.9165678,"price_display":"24.92","price_state":"stated","total_value":99666.2712,"total_display":"99,666.27","total_whole":"99,666","shares_owned_after":100950.0,"shares_owned_after_display":"100,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-17","filed_date":"2019-04-18","scope":"insider","n_lines":2},{"id":8042313,"accession":"0001567619-19-001375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-001375","line_url":"/filing/0001567619-19-001375","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001691090","owner_name":"Feener Edward P.","owner_display_name":"Feener Edward P.","owner_url":"/insider/0001691090","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.55247,"price_display":"19.55","price_state":"stated","total_value":78209.88,"total_display":"78,209.88","total_whole":"78,210","shares_owned_after":104034.0,"shares_owned_after_display":"104,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Officer (CHIEF SCIENTIFIC OFFICER)","n_filings":24,"first_seen":"2019-01-18","last_seen":"2024-05-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001691090","retrieved_at":"2026-08-26T17:58:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}